Tobias Lanz is an MD and academic research scientist in the laboratory of Prof. William Robinson at the Department of Rheumatology/Immunology at Stanford School of Medicine. Dr. Lanz’s research focuses on B cell biology in autoimmune and infectious diseases, including multiple sclerosis (MS), lupus, rheumatoid arthritis, and COVID-19, and explores viral and microbial triggers of autoimmunity. Recently Dr. Lanz was the first author of a breakthrough study that connects Epstein Barr virus directly to the MS disease process. The study demonstrated high-affinity molecular mimicry between the EBV transcription factor EBNA1and the human central nervous system protein GlialCAM.